Evidence map›Paper›PMID 32455909›Full record

ArticleInternational journal of molecular sciences2020

Targeted Delivery of Iron Oxide Nanoparticle-Loaded Human Embryonic Stem Cell-Derived Spherical Neural Masses for Treating Intracerebral Hemorrhage.

Min Kyoung Kang, Tae Jung Kim, Young-Ju Kim, Lamie Kang, Jonghoon Kim, Nohyun Lee, Taeghwan Hyeon, Mi-Sun Lim, Hee Jung Mo, Jung Hwan Shin and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Nanobiotechnologies for stroke treatment.Nanomedicine (London, England) · 2025
    Review
  5. Review
  6. Article
  7. [Research progress on the effect of iron oxide nanoparticles in macrophage polarization].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Advances of nanotechnology for intracerebral hemorrhage therapy.Frontiers in bioengineering and biotechnology · 2023
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Min Kyoung KangDepartment of Neurology, Seoul National University Hospital, Seoul 03080, Korea.
Tae Jung KimDepartment of Neurology, Seoul National University Hospital, Seoul 03080, Korea.
Young-Ju KimBiomedical Research Institute, Seoul National University Hospital, Seoul 03080, Korea.
Lamie KangBiomedical Research Institute, Seoul National University Hospital, Seoul 03080, Korea.
Jonghoon KimCenter for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Korea.
Nohyun LeeSchool of Advanced Materials Engineering, Kookmin University, Seoul 02707, Korea.
Taeghwan HyeonCenter for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Korea.
Mi-Sun LimResearch and Development Center, Jeil Pharmaceutical Co. Ltd., Yongin-si, Gyeonggi-do 17172, Korea.
Hee Jung MoDepartment of Neurology, Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do 14068, Korea.
Jung Hwan ShinDepartment of Neurology, Seoul National University Hospital, Seoul 03080, Korea.ORCID 0000-0003-4182-3612
Sang-Bae KoDepartment of Neurology, Seoul National University Hospital, Seoul 03080, Korea.
Byung-Woo YoonDepartment of Neurology, Seoul National University Hospital, Seoul 03080, Korea.
Seoul National University · KRSeoul National University Hospital · KRHallym University Dongtan Sacred Heart Hospital · KRKookmin University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated the potential of iron oxide nanoparticle-loaded human embryonic stem cell (ESC)-derived spherical neural masses (SNMs) to improve the transportation of stem cells to the brain, ameliorate brain damage from intracerebral hemorrhage (ICH), and recover the functional status after ICH under an external magnetic field of a magnet attached to a helmet. At 24 h after induction of ICH, rats were randomly separated into three experimental groups: ICH with injection of phosphate-buffered saline (PBS group), ICH with intravenous injection of magnetosome-like ferrimagnetic iron oxide nanocubes (FION)-labeled SNMs (SNMs* group), and ICH with intravenous injection of FION-labeled SNMs followed by three days of external magnetic field exposure for targeted delivery by a magnet-embedded helmet (SNMs*+Helmet group). On day 3 after ICH induction, an increased Prussian blue-stained area and decreased swelling volume were observed in the SNMs*+Helmet group compared with that of the other groups. A significantly decreased recruitment of macrophages and neutrophils and a downregulation of pro-inflammatory cytokines followed by improved neurological function three days after ICH were observed in the SNMs*+Helmet group. Hemispheric atrophy at six weeks after ICH was significantly decreased in the SNMs*+Helmet group compared with that of the PBS group. In conclusion, we have developed a targeted delivery system using FION tagged to stem cells and a magnet-embedded helmet. The targeted delivery of SNMs might have the potential for developing novel therapeutic strategies for ICH.

Indexed as

AnimalsBehavior Rating ScaleBrainCell SurvivalCerebral HemorrhageCyclooxygenase 2CytokinesHuman Embryonic Stem CellsHumansInflammationInjections, IntravenousMagnetic Field TherapyMagnetic Iron Oxide NanoparticlesMaleNeural Stem CellsRatsCyclooxygenase 2Cytokineshuman embryonic stem cellintracerebral hemorrhageiron oxide nanoparticlemagnet-embedded helmetspherical neural massestargeted delivery

Identifiers

PMID32455909
PMCPMC7279437
OpenAlexW3027443362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.